|
Re: Kick the can
|
|
Resverlogix Corp.
|
Aug 24, 2017 09:08PM
|
|
Re: Market cap
|
|
Resverlogix Corp.
|
Dec 09, 2017 06:58PM
|
|
Relax Non Zenith Holders
|
|
Resverlogix Corp.
|
Nov 16, 2016 04:21PM
|
|
Re: RVXCF New 52 week high, $3.59 USD....
|
|
Resverlogix Corp.
|
Apr 24, 2019 03:55PM
|
|
Re: Investing in the fog
|
|
Resverlogix Corp.
|
Oct 28, 2016 02:12PM
|
|
Re: Actions Speak Louder Than Words
|
|
Resverlogix Corp.
|
Nov 21, 2016 07:22PM
|
|
Re: Boehringer.Ingelheim
|
|
Resverlogix Corp.
|
Aug 26, 2016 06:13PM
|
|
Re: A Homecoming of Sorts...book value question
|
|
Resverlogix Corp.
|
Sep 21, 2015 02:59PM
|
|
Re: Presentation a liitle over an hour away
|
|
Resverlogix Corp.
|
Jun 19, 2017 07:20PM
|
|
Re: A Homecoming of Sorts...book value question
|
|
Resverlogix Corp.
|
Sep 21, 2015 05:19PM
|
|
Re: Investing in the fog
|
|
Resverlogix Corp.
|
Oct 28, 2016 03:45PM
|
|
Re: A Homecoming of Sorts...book value question
|
|
Resverlogix Corp.
|
Sep 21, 2015 05:32PM
|
|
Re: everything r v x is down 4% to around 24%
|
|
Resverlogix Corp.
|
Jan 27, 2021 05:31PM
|
|
Re: A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease
|
1
|
Resverlogix Corp.
|
Sep 25, 2015 10:31AM
|
|
Re: Filled!
|
1
|
Zenith Epigenetics
|
Jan 21, 2021 10:29PM
|
|
Re: FDA
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 02:19PM
|
|
Re: Choosing Between Two License Deals
|
1
|
Resverlogix Corp.
|
Sep 26, 2016 03:59PM
|
|
Re: How come?
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 28, 2020 06:29PM
|
|
Re: RVX TO HOST R&D UPDATE FEATURING KEY OPINION LEADERS IN CVD AND RENAL DISEASE
|
1
|
Resverlogix Corp.
|
Oct 04, 2016 07:04PM
|
|
Re: Renal trial delayed (again)
|
1
|
Resverlogix Corp.
|
Sep 30, 2017 02:23PM
|
